ArticleJournal of the American Medical Informatics Association : JAMIA2025
Electronic health records-based algorithms to screen for U.S. Centers for Disease Control and Prevention tier 1 genetic diseases: a scoping review.
Article in Journal of the American Medical Informatics Association : JAMIA, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Article
- Integrating Genetic Counseling in Cardiology Clinics: From Guidelines to Practice.Reviews in cardiovascular medicine · 2026Article
- Artificial intelligence in ovarian cancer: advancing in precision diagnosis and clinical management.Frontiers in immunology · 2026Review
- Harnessing data to advance health and health equity.Journal of the American Medical Informatics Association : JAMIA · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
objectiveMissed diagnosis of genetic conditions is a persistent challenge in clinical care, particularly for familial hypercholesterolemia (FH), hereditary breast and ovarian cancer (HBOC), and Lynch syndrome-conditions designated by the U.S. Centers for Disease Control and Prevention (CDC) as Tier 1 genomic applications. This scoping review summarizes evidence on the use of electronic health record (EHR)-based algorithms to identify individuals with these conditions. MATERIALS AND
methodsWe conducted a scoping review using the JBI Manual for Evidence Synthesis and reported results according to PRISMA-ScR guidelines. We searched Ovid MEDLINE, Embase, and Web of Science through October 2024 for studies evaluating EHR-based algorithms to identify individuals with FH, HBOC, or Lynch syndrome. Eligible studies addressed (1) performance of algorithms in detecting clinically or genetically confirmed cases or (2) outcomes from the implementation of algorithms in unselected populations with follow-up to identify new diagnoses.
resultsOf 598 articles screened, 22 met inclusion criteria. Most studies (20/22) focused on FH. Fourteen FH studies assessed algorithm performance, and 7 reported prospective implementation. FH algorithm performance varied widely (AUROC range 0.78-0.95), with machine learning models outperforming rule-based approaches. Implementation studies reported positive predictive values ranging from 11% to 67%. Only two studies addressed HBOC or Lynch syndrome, both using rules-based algorithms with limited sensitivity. DISCUSSION: Machine learning models consistently outperform rules-based algorithms relying on clinical criteria, but limited evidence exists for HBOC and Lynch syndrome.
conclusionsEarly identification of CDC Tier 1 genetic conditions through EHR-based screening algorithms holds promise but will require both technical and implementation advances to realize improved patient care and outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.